SRS in Combination With Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases

Dear Editor, I am writing to you in order to highlight some miscalculations in an article published in the journal of Technology in Cancer Research & Treatment, entitled; “SRS in Combination with Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases” by Khan, et al.(1) The...

Descripción completa

Detalles Bibliográficos
Autores principales: Badrigilan, Samireh, Choupani, Jalal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607808/
https://www.ncbi.nlm.nih.gov/pubmed/33111619
http://dx.doi.org/10.1177/1533033820965607
_version_ 1783604717802225664
author Badrigilan, Samireh
Choupani, Jalal
author_facet Badrigilan, Samireh
Choupani, Jalal
author_sort Badrigilan, Samireh
collection PubMed
description Dear Editor, I am writing to you in order to highlight some miscalculations in an article published in the journal of Technology in Cancer Research & Treatment, entitled; “SRS in Combination with Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases” by Khan, et al.(1) These miscalculations changed the derived conclusion about median survival time, and adverse effects in the selected treatment groups. So, amending these miscalculations may help readers in future research decisions.
format Online
Article
Text
id pubmed-7607808
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-76078082020-11-13 SRS in Combination With Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases Badrigilan, Samireh Choupani, Jalal Technol Cancer Res Treat Letter to the Editor Dear Editor, I am writing to you in order to highlight some miscalculations in an article published in the journal of Technology in Cancer Research & Treatment, entitled; “SRS in Combination with Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases” by Khan, et al.(1) These miscalculations changed the derived conclusion about median survival time, and adverse effects in the selected treatment groups. So, amending these miscalculations may help readers in future research decisions. SAGE Publications 2020-10-28 /pmc/articles/PMC7607808/ /pubmed/33111619 http://dx.doi.org/10.1177/1533033820965607 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Letter to the Editor
Badrigilan, Samireh
Choupani, Jalal
SRS in Combination With Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases
title SRS in Combination With Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases
title_full SRS in Combination With Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases
title_fullStr SRS in Combination With Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases
title_full_unstemmed SRS in Combination With Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases
title_short SRS in Combination With Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases
title_sort srs in combination with ipilimumab: a promising new dimension for treating melanoma brain metastases
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607808/
https://www.ncbi.nlm.nih.gov/pubmed/33111619
http://dx.doi.org/10.1177/1533033820965607
work_keys_str_mv AT badrigilansamireh srsincombinationwithipilimumabapromisingnewdimensionfortreatingmelanomabrainmetastases
AT choupanijalal srsincombinationwithipilimumabapromisingnewdimensionfortreatingmelanomabrainmetastases

Ejemplares similares